DN4.99 TCR-T cells, therefore, spare healthy CD1c-expressing cells whilst effectively targeting CD1c-expressing leukemia blasts ex vivo, supporting the further preclinical investigation of cell therapy based on this TCR. The gene discussed is CD1C; the disease is leukemia.